This content is intended for U.S. physicians only.
Professional Education for Zephyr Valve Treating Physicians
Have you been limited in your treatment options for patients suffering from advanced COPD/emphysema? Until recently, there have been limits on what medications and supplemental oxygen could deliver without resorting to surgical treatments.
The Zephyr Valve is another option! Pulmonx developed the Zephyr Valve treatment as a minimally-invasive lung volume reduction procedure that reduces hyperinflation and gas trapping in patients with emphysema.
Zephyr Valve therapy can benefit:
- Patients who are not responding to optimal medical management
- Patients with homogeneous or heterogeneous emphysema
- Patients with upper lobe or lower lobe predominant emphysema
- Patients who may not qualify for more invasive procedures such as lung volume reduction surgery or transplant
Already have login information?
Complications of the Zephyr Endobronchial Valve treatment can include but are not limited to pneumothorax, worsening of COPD symptoms, hemoptysis, pneumonia, dyspnea and, in rare cases, death.